Back

Choose your region

FamiCord Group continues international expansion

Yasam is the oldest Turkish stem cell bank and has been operating for over 10 years. Yasam, like all FamiCord Group banks, has the highest quality standards. By 2013, it had provided on 4 occasions deposited umbilical cord blood to treat children. Yasam has its own specialized laboratory, providing the highest standards of quality class GMP laboratory located in Ankara.

Turkey is one of the 20 largest and fastest-growing economies in the world. Turkish society is very young, the average age is 29.7 years. Turkey also boasts a high birth rate, in 2010 it was reported to be 2.08. More than three-quarters of Turkish citizens are living in rapidly developing cities, five of which (Istanbul, Ankara, Izmir, Bursa, Adana) have more than two million inhabitants. Turkey is currently in the dynamic phase of growth.

“With this transaction, the Group FamiCord strengthens its position as European leader. What’s more – we see great potential for development of the Turkish company, which, from the beginning of its activity, has gained a large share of the Turkish market. The company currently occupies 3rd position among stem cell banks operating in Turkey. We believe that with our support it will be able to accelerate the pace of development.” – said Jakub Baran, CEO of FamiCord Group, justifying the bank’s decision. “The key to success is a management team which has a vision” – he added. The company will focus on business development, and building awareness of the family cord blood banking in Turkey.

Recently added

  • Infantile cerebral palsy – Convincing evidence for the use of perinatal stem cells Leipzig, July 15, 2025 - Cerebral palsy (CP) continues to be one of the most common motor disabilities in childhood and is associated with permanent movement restrictions and spasticity. The therapeutic potential of stem cells from umbilical cord blood and tissue was discussed at the 37th Annual Meeting of the European Academy Of Childhood-onset Disabilities (EACD) and the 4th Meeting of the International Alliance of Academies of C hildhood Disability (IAACD) from June 24 - 28, 2025 in Heidelberg. As part of a symposium supported by FamiCord AG, international experts presented the current state of research and reported on the results from clinical practice. Read more
  • FamiCord Group’s Dubai Laboratory Earns Prestigious AABB Accreditation Dubai, UAE – [3.06.2025] – FamiCord Group, the largest cord blood bank in Europe, proudly announces that its state-of-the-art laboratory in Dubai has received the prestigious accreditation from the Association for the Advancement of Blood & Biotherapies (AABB) – a globally recognized standard of excellence in the field of cellular and blood banking services. Read more